CLINICAL_TRIALS
trial_result
· 2021-09-10
Clinical Trial Update: Early Intervention in Allergic Patients [Phase 4]
Summary
Phase 4 clinical trial update on early intervention in allergic rhinitis due to weed pollen involving montelukast.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Tongren Hospital | Conditions: Allergic Rhinitis Due to Weed Pollen, Montelukast | Phase 4 | Status: COMPLETED